共 40 条
[1]
Mardirossian G., Wu C., Hnatowich D.J., The stability in liver homogenates of indium-111 and yttrium-90 attached to antibody via two popular chelators, Nucl. Med. Biol., 20, pp. 65-74, (1993)
[2]
Motta-Hennessy C., Sharkey R.M., Goldenberg D.M., Metabolism of indium-lll-labeled murine monoclonal antibody in tumor and normal tissue of the athymic mice, J. Nucl. Med., 31, pp. 1510-1519, (1990)
[3]
Kinuya S., Jeong J.M., Garmestani K., Saga T., Camera L., Brechbiel M.W., Gansow O.A., Carrasquillo J.A., Neumann R.D., Paik C.H., Effect of metabolism on retention of indium-lll-labeled monoclonal antibody in liver and blood, J. Nucl. Med., 35, pp. 1851-1857, (1994)
[4]
Sakahara H., Saga T., Endo K., Hattori N., Hosono M., Kobayashi H., Shirato M., Yamamuro T., Toyama S., Arano Y., Yokoyama A., Konishi J., In Vivo instability of reduction-mediated 99m Tc-labeled monoclonal antibody, Nucl. Med. Biol., 20, pp. 617-623, (1993)
[5]
Hnatowich D.J., Mardirossian G., Rusckowski M., Fogarasi M., Virzi F., Winnard P., Directly and indirectly technetium-99m-labeled antibodies: a comparison of in vitro and animal in vivo properties, J. Nucl. Med., 34, pp. 109-119, (1993)
[6]
Lashford L.S., Davies A.G., Richardson R.B., Bourne S.P., Bullimore J.A., Eckert H., Kemshead J.T., Coakham H.B., A pilot study of 131I monoclonal antibodies in the therapy of leptomeningeal tumors, Cancer, 61, pp. 857-868, (1988)
[7]
Press O.W., Eary J.F., Appelbaum F.R., Martin P.J., Badger C.C., Nelp W.B., Glenn S., Butchko G., Fisher D., Porter B., Matthews D.C., Fisher L.D., Berstein I.D., Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support, N. Eng. J. Med., 329, pp. 1219-1224, (1993)
[8]
Kaminski M.S., Zasadny K.R., Francis I.R., Milik A.W., Ross C.W., Moon S.D., Crawford S.M., Burgess J.M., Petry N.A., Butchko G.M., Glenn S.D., Wahl R.L., Radioimmunotherapy of B-cell lymphoma with [131I]-anti-Bl (anti-CD20) antibody, N. Engl. J. Med., 329, pp. 459-465, (1993)
[9]
Bigner D.D., Brown M., Coleman R.E., Friedman A.H., Friedman H.S., McLendon R.E., Bigner S.H., Wikstrand C.J., Pegram C.N., Kerby T., Zalutsky M.R., Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Mel-14 F(ab')2-a preliminary report, J. Neuro. Oncol., (1995)
[10]
Eary J.F., Krohn K.A., Kishore R., Nelp W.B., Radiochemistry of halogenated antibodies, Antibodies in Radiodiagnosis and Therapy, pp. 83-102, (1989)